Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • Emerging therapeutic strategies in breast cancer (Oct 2026)
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Mouse offspring conceived by in vitro fertilization exhibit accelerated reproductive aging through premature ovarian insufficiency
Eric A. Rhon-Calderon, Cassidy N. Hemphill, Alexandra J. Savage, Ana Domingo-Muelas, Zhengfeng Liu, Christopher J. Krapp, Laren Riesche, Nicolas Plachta, Richard M. Schultz, Marisa S. Bartolomei
Eric A. Rhon-Calderon, Cassidy N. Hemphill, Alexandra J. Savage, Ana Domingo-Muelas, Zhengfeng Liu, Christopher J. Krapp, Laren Riesche, Nicolas Plachta, Richard M. Schultz, Marisa S. Bartolomei
View: Text | PDF
Research Article Development Reproductive biology

Mouse offspring conceived by in vitro fertilization exhibit accelerated reproductive aging through premature ovarian insufficiency

  • Text
  • PDF
Abstract

Reproductive aging is characterized by a progressive decline of reproductive function, with broad implications for overall health and longevity. Environmental factors, including assisted reproductive technologies (ARTs), can accelerate reproductive aging by promoting premature ovarian insufficiency in females. In vitro fertilization (IVF), though widely used and generally considered safe, has been associated with lasting effects on offspring health. Using a mouse model that closely approximates human IVF, we demonstrated that IVF accelerated reproductive aging in female offspring by inducing premature ovarian insufficiency. IVF-conceived female mice exhibited altered ovarian function, reduced follicle reserve, disrupted endocrine profiles, and transcriptomic and epigenetic changes consistent with premature reproductive decline. These findings reveal long-term consequences of IVF on female reproductive health and highlight the need to understand how early-life interventions influence reproductive longevity.

Authors

Eric A. Rhon-Calderon, Cassidy N. Hemphill, Alexandra J. Savage, Ana Domingo-Muelas, Zhengfeng Liu, Christopher J. Krapp, Laren Riesche, Nicolas Plachta, Richard M. Schultz, Marisa S. Bartolomei

×

Figure 1

Mouse model and general parameters.

Options: View larger image (or click on image) Download as PowerPoint
Mouse model and general parameters.
(A) Mouse model: Naturally conceived...
(A) Mouse model: Naturally conceived embryos (Natural) were generated using B6/SJL male mice and CF-1 female mice, and IVF embryos were produced using capacitated sperm from B6/SJL mice and eggs from superovulated CF-1 mice. After embryo culture to the blastocyst stage, 10 blastocysts were transferred to pseudopregnant females. At E13.5, indicated by the arrow, pregnant females from both groups were euthanized, fetuses were collected by c-section, and fetal gonads were dissected for molecular analysis. At E18.5, pregnant females from both groups were c-sectioned, and fetuses were delivered and collected for molecular analysis. For adult cohorts, c-section–delivered pups at E18.5 (natural) or E19.0 (IVF) were fostered with WT dams and monitored until 12 or 39 weeks of age. Shown are (B) body weights before 6 hours fasting; (C) ovarian weights; (D) ovary to body weight ratios; (E) serum estradiol levels; and (F) progesterone levels assayed by ELISA. (G) The ratio of mtDNA relative to nDNA measured in whole ovarian DNA by RT-qPCR is depicted for all time points (see Methods for primers). Data are presented as the mean ± SEM, and sample sizes are indicated below each panel as the number of animals (litters). The black line represents the mean of each group. Normality was assessed using the Shapiro-Wilk test. Data that did not meet the normality assumption were analyzed using a nonparametric Mann-Whitney U test, whereas normally distributed data were analyzed using an unpaired 2-tailed t test with Welch’s correction. *P < 0.05 and **P < 0.01, for IVF groups compared with Naturals.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts